Scott Michael Galovan insider trades

Open-market stock purchases and sales by Scott Michael Galovan, SVP, Chief Financial Officer at Avanos Medical, Inc, from SEC Form 4 filings since Mar 6, 2026.

Recent trades

DateStockTradeValue
Jul 27, 2026AVNS Avanos Medical, IncSold (not open market)$3.4M
Jul 27, 2026AVNS Avanos Medical, IncSold (not open market)$321K
Jul 27, 2026AVNS Avanos Medical, IncBought (not open market)—
Jul 27, 2026AVNS Avanos Medical, IncSold (not open market)$2.4M
Jul 27, 2026AVNS Avanos Medical, IncSold (not open market)$953K
Apr 22, 2026AVNS Avanos Medical, IncSold (not open market)$104K
Mar 13, 2026AVNS Avanos Medical, IncBought (not open market)—
Mar 13, 2026AVNS Avanos Medical, IncBought (not open market)—
Mar 13, 2026AVNS Avanos Medical, IncBought (not open market)—
Mar 13, 2026AVNS Avanos Medical, IncBought (not open market)—
Mar 13, 2026AVNS Avanos Medical, IncBought (not open market)—
Mar 13, 2026AVNS Avanos Medical, IncBought (not open market)—
Mar 9, 2026AVNS Avanos Medical, IncSold (not open market)$14.9K
Mar 6, 2026AVNS Avanos Medical, IncSold (not open market)$14.6K
Mar 6, 2026AVNS Avanos Medical, IncBought (not open market)$81.5K
Mar 6, 2026AVNS Avanos Medical, IncSold (not open market)$32.5K
Mar 6, 2026AVNS Avanos Medical, IncSold (not open market)$28.1K

Companies traded

  • AVNS Avanos Medical, Inc: other filings, last Jul 27, 2026

Get free alerts when Scott Michael Galovan files a new trade →